PHILADELPHIA, Nov. 10, 2025 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the presentation of new preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback